Le Lézard
Classified in: Health
Subjects: PDT, PET, ANW

RxActuator Introduces the First Wearable Animal Drug Delivery Pump - Launches Online Sales


TUCSON, Ariz., Nov. 26, 2019 /PRNewswire-PRWeb/ -- RxActuator, Inc. is the manufacturer of a proprietary and revolutionary veterinary medical device - the Mini-Infusertm Pump. This Wearable Subcutaneous Constant Rate Infusion (SQ-CRI) pump for animals is the first constant rate infusion pump designed specifically for animals.

The Mini-Infuser Pump is easy to use, allows the small companion animal patient to maintain mobility during drug delivery, reduces risk of over- or under-medicating, and gives the pet owner the ability to take their beloved friend home during drug delivery.

"The RxActuator Mini-Infusertm Pump has changed the way we practice. We no longer need to keep all patients in the hospital or refer them out for overnight pain management. We can cost-effectively use the RxActuator Mini-Infusertm Pump and a medical pet shirt to keep these patients comfortable for 48 hours. Love it!" - James S. Gaynor, DVM, MS, Diplomate, American College of Veterinary Anesthesia & Analgesia.

The RxActuator team has attended veterinarian trade shows around the country creating buzz about the Mini-Infuser pump. The device is now available for purchase by Veterinarians on their website at rxactuator.net. The Mini-Infuser pump kit comes with all the materials needed for Veterinarians and their staff to safely administer Veterinarian supplied medicine to your canine patient.

"For the first time, IV based drug therapy can be given to dogs and cats subcutaneously, thereby eliminating tangling IV lines. These companion animals can get back up on their feet, feel the freedom of mobility and move as their natural recovery allows." - Doug Nutter, Chief Marketing Officer

For information about RxActuator and the Mini-Infuser Pump, please visit their website. https://www.rxactuator.net/

Contact info/Media Inquiries:
Doug Nutter
Chief Marketing Officer
[email protected]
810-964-3248

 

SOURCE RxActuator, Inc.


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: